Parental Obesity and Offspring Serum Alanine and Aspartate Aminotransferase Levels: The Framingham Heart Study

Gastroenterology

Volumn 134, Issue 4, 2008, Pages

  Loomba, Rohit ^a   Hwang, Shih Jen ^b   O'Donnell, Christopher J ^b,c   Ellison, R Curtis ^b,d   Vasan, Ramachandran S ^b,d   D'Agostino Sr , Ralph B ^b,e   Liang, T Jake ^a   Fox, Caroline S ^b,f  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b FRAMINGHAM HEART STUDY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Boston University   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; ONSET AGE; PRIORITY JOURNAL; PROGENY;

EID: 41349119137     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.01.037     Document Type: Article

References (42)

1. Seidell J.C. Obesity, insulin resistance and diabetes-a worldwide epidemic. Br J Nutr 83 suppl 1 (2000) S5-S8
2. Yoon K.H., Lee J.H., Kim J.W., et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 368 (2006) 1681-1688
3. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
4. Li C., Ford E.S., McGuire L.C., et al. Increasing trends in waist circumference and abdominal obesity among U.S. adults. Obesity (Silver Spring) 15 (2007) 216-224
5. Peters E.T., Seidell J.C., Menotti A., et al. Changes in body weight in relation to mortality in 6441 European middle-aged men: the Seven Countries Study. Int J Obes Relat Metab Disord 19 (1995) 862-868
6. Menotti A., Lanti M., Maiani G., et al. Determinants of longevity and all-cause mortality among middle-aged men. Role of 48 personal characteristics in a 40-year follow-up of Italian Rural Areas in the Seven Countries Study. Aging Clin Exp Res 18 (2006) 394-406
7. Ogden C.L., Flegal K.M., Carroll M.D., and Johnson C.L. Prevalence and trends in overweight among US children and adolescents, 1999-2000 [see comment]. JAMA 288 (2002) 1728-1732
8. Ruhl C.E., and Everhart J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States [see comment]. Gastroenterology 124 (2003) 71-79
9. Ioannou G.N., Boyko E.J., and Lee S.P. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 101 (2006) 76-82
10. Neuschwander-Tetri B.A. Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci 330 (2005) 326-335
11. Bedogni G., Miglioli L., Masutti F., et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42 (2005) 44-52
12. Meltzer A.A., and Everhart J.E. Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans. Am J Epidemiol 146 (1997) 565-571
13. Hamaguchi M., Kojima T., Takeda N., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143 (2005) 722-728
14. Rankinen T., Zuberi A., Chagnon Y.C., et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 14 (2006) 529-644
15. Ioannou G.N., Boyko E.J., and Lee S.P. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 101 (2006) 76-82
16. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
17. Browning J.D., Kumar K.S., Saboorian M.H., et al. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol 99 (2004) 292-298
18. Struben V.M., Hespenheide E.E., and Caldwell S.H. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 108 (2000) 9-13
19. Willner I.R., Waters B., Patil S.R., et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 96 (2001) 2957-2961
20. Bathum L., Petersen H.C., Rosholm J.U., et al. Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem 47 (2001) 81-87
21. Cupples L.A., and DARB. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Study, 30-year follow-up. In: Kannel W.B., Polf P.A., and Garrison R.J. (Eds). The Framingham Heart Study: an epidemiological investigation of cardiovascular disease (1987), Government Printing Office, Washington, DC NIH Publication 87-203, section 34
22. Feinleib M., Kannel W.B., Garrison R.J., et al. The Framingham Offspring Study. Design and preliminary data. Prev Med 4 (1975) 518-525
23. Henry R.J., Chiamori N., Golub O.J., et al. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol 34 (1960) 381-398
24. Prati D., Taioli E., Zanella A., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137 (2002) 1-10
25. Chang Y., Ryu S., Sung E., et al. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 53 (2007) 686-692
26. Abdelmalek M.F., Liu C., Shuster J., et al. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 4 (2006) 1162-1169
27. Merriman R.B., Aouizerat B.E., and Bass N.M. Genetic influences in nonalcoholic fatty liver disease. J Clin Gastroenterol 40 Suppl 1 (2006) S30-S33
28. Day C.P. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int 26 (2006) 1021-1028
29. Kazumi T., Kawaguchi A., and Yoshino G. Associations of middle-aged mother's but not father's body mass index with 18-year-old son's waist circumferences, birth weight, and serum hepatic enzyme levels. Metabolism 54 (2005) 466-470
30. Delplanque J., Barat-Houari M., Dina C., et al. Linkage and association studies between the proopiomelanocortin (POMC) gene and obesity in Caucasian families. Diabetologia 43 (2000) 1554-1557
31. Bell C.G., Meyre D., Samson C., et al. Association of melanin-concentrating hormone receptor 1 5′ polymorphism with early-onset extreme obesity. Diabetes 54 (2005) 3049-3055
32. Farooqi I.S., Wangensteen T., Collins S., et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 356 (2007) 237-247
33. Friedman J.M. Leptin and the regulation of body weight. Harvey Lect 95 (1999) 107-136
34. Cao Q., Mak K.M., and Lieber C.S. Leptin enhances alpha1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways. J Cell Biochem 97 (2006) 188-197
35. Ding X., Saxena N.K., Lin S., et al. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol 166 (2005) 1655-1669
36. Kitade M., Yoshiji H., Kojima H., et al. Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats. Hepatology 44 (2006) 983-991
37. Reik W., and Walter J. Evolution of imprinting mechanisms: the battle of the sexes begins in the zygote. Nat Genet 27 (2001) 255-256
38. Nordfjall K., Larefalk A., Lindgren P., et al. Telomere length and heredity: indications of paternal inheritance. Proc Natl Acad Sci U S A 102 (2005) 16374-16378
39. Salvaggio A., Periti M., Miano L., et al. Body mass index and liver enzyme activity in serum. Clin Chem 37 (1991) 720-723
40. Kojima H., Sakurai S., Uemura M., et al. Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. Alcohol Clin Exp Res 29 12 suppl (2005) 259S-263S
41. Panteghini M. Aspartate aminotransferase isoenzymes. Clin Biochem 23 (1990) 311-319
42. Guzman J., Petty R.E., and Malleson P.N. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. J Rheumatol 21 (1994) 739-743